Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

COVID-19 Study Of Gilead’s Remdesivir Using Ebola-Style Adaptive Platform Trial

Mar 17 2020

• By Bridget Silverman

COVID-19 SARS,Coronaviridae , SARS-CoV, SARSCoV, virus 2020 , MERS-CoV ,chinese virus 2019-nCoV

Related Content

Keeping Track: Biosimilars, Novel Approvals, And Ebola

Nov 11 2019

Master Protocols Are Both Welcome And Inevitable – US FDA's Woodcock

Jul 07 2017

Coronavirus: Gilead Readies For Remdesivir Ramp Up, Questions On Profit Motive

Mar 03 2020

Ebola Success For Regeneron’s Triple Antibody Cocktail

Aug 13 2019

Related Companies

Gilead Sciences, Inc.

Mapp Biopharmaceutical

Regeneron Pharmaceuticals, Inc.

Additional Topics

United States Coronavirus COVID-19 Vaccines Research & Development Regulation Drug Approval Standards Clinical Trials

More from Vaccines

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window